Table 2.
Characteristic | Persistent AF | Paroxysmal AF | P |
---|---|---|---|
Baseline AF cycle length, ms | 170±21 | 189±13 | 0.03 |
Patients with detected sources | 28/29 (97%) | 7/7 (100%) | |
Patients in whom FIRM was completed | 26/29 (89.7%) | 6/7 (85.7%) | |
Patients reaching acute end point | 24/29 (82.8%) | 7/7 (100%) | |
No. of concurrent AF sources | 2.4±1.1 | 1.9±0.7 | 0.23 |
No. of rotors, %* (LA/RA) | 74.1% (29/14) | 61.5% (6/2) | |
No. of focal impulses, %* (LA/RA) | 25.9% (15/0) | 38.5% (5/0) | |
Primary source | |||
No. of rotors (LA, RA) | 18 (14/4) | 4 (3/1) | |
No. of focal impulses (LA, RA) | 6 (6/0) | 3 (3/0) | |
Precession area, cm2 | 2.5±1.7 | 1.7±0.5 | 0.3 |
FIRM-ablation time to AF termination | 2.5 (IQR, 1–3) | 3.0 (IQR, 1–4.1) | 0.49 |
Primary source/min¶ | (4.5±7.3) | (3.9±4.1) | |
Total FIRM-ablation time | 19.9 (IQR, 3.1–27.5) | 8.9 (IQR, 3–10.5) | 0.01 |
All sources/min‡ | 17.5±10.5 | 7.7±4.2 |
AF indicates atrial fibrillation; FIRM, focal impulse and rotor modulation; LA, left atrial; and RA, right atrial.
Percentages are within each patient group;
duration of FIRM ablation at the rotor/focal source where AF terminated then was nonreinducible; and
total duration of FIRM ablation for all sources (before conventional ablation).